Podcasts

The CAP's Advocacy efforts have included several touchpoints with the Administration and Congress. In this CAPcast, Jonathan Myles, MD, FCAP, will discuss the CAP’s actions this year to influence the government’s response to the pandemic.

This CAPcast interview features the audio recording of a recent CAP Zoom media briefing, 'The Rapidly Changing COVID-19 Testing Landscape: Vaccines, Variants, and Health Disparities.'

Some biomarkers are already covered in what has become routine testing in many laboratories, affording pathologists an opportunity to play a central role in developing and implementing these biomarkers in ways to improve patient care, explains Eric Walk, MD, FCAP, Chief Medical & Scientific Officer and Senior VP of Medical & Scientific Affairs with Roche Diagnostics, in this CAPcast.

In this CAPcast, Gary Horowitz, MD, FCAP, Chair of the CAP’s Accuracy-Based Programs Committee, explains why it’s important to incorporate accuracy-based testing into your quality process.

Surveys have shown hesitancy among African Americans to take the COVID-19 vaccine, much to the concern of physicians and public health experts, who emphasize the perils posed by immunization gaps in certain populations to overall public health.

In this CAPcast interview, Tim Aukerman, Corporate Quality Assessment Manager at Quest Diagnostics, discusses his experience with directly transmitting PT results to the CAP via the Data Innovations Instrument Manager.

There are several methods for workup of urinary tract infections or UTIs and utilizing the appropriate test(s) on the appropriate patients can allow for prompt and appropriate treatment and symptom relief, as well as reduce unnecessary testing and unnecessary treatment with antimicrobials, explains Dr. Stacy Beal, in this CAPcast.

In this CAPcast, Dr. Vaught discusses the special challenges involved in developing protocols to work with biospecimens collected from patients during an infectious disease emergency, as well as the role that biobanks play in the development of COVID vaccines and therapies.

In this CAPcast interview, Dr. Thomas Wheeler discusses the survey’s findings, which confirm the pandemic's ongoing adverse effects on pathologists as the United States has relied on COVID-19 testing throughout this national crisis.

Introducing a new antigen proficiency testing program for SARS-CoV-2 virus to complement existing programs for molecular and serology PT, the CAP now offers laboratories a complete suite of PT and quality improvement programs for all COVID-19-related testing.

To meet the demand for SARS-CoV-2 molecular testing, many laboratories have expanded testing capacity by adding multiple molecular instruments. However, this has left laboratories with questions regarding proficiency testing (PT) requirements for these additional instruments, as two CAP members, Dr. Bobbi Pritt and Dr. Lauren Pearson, explain in this CAPcast interview.

Regularly published research findings seem to question the validity or efficacy of many of the testing methods – and PCR is no different, as Dr. Sophia Yohe explains in this CAPcast interview.

In this interview, Dr. Duong will discuss what pathologists need to know during this important transition, and important tips to gain confidence when you first start out in practice.

Amidst the trauma of the COVID-19 pandemic, the autopsies from early COVID patients revealed significant findings, explained Mt Sinai pathologist Mary Fowkes, MD, FCAP, in this CAPcast before her sudden death in November 2020.

Laboratories must report cumulative antimicrobial sensitivity information to the medical staff at least annually under accreditation requirements from both the CAP and the Joint Commission. Despite requirements to do this at the institutional level, there is no national reporting or convenient way for the institution to monitor trends or compare rates recorded by other laboratories, explains Dr. Ron Schifman in this CAPcast interview.

Recent U.S. physician workforce counts have understated by about 40% the number of actively practicing pathologists. In this CAPcast interview, two CAP member leaders—past president Stanley Robboy and Governor Dr. Donald Karcher—provide background on the misevaluation, its impact, and future policy implications of their new research.

In a laboratory setting with fast-paced changes and heavy demands on staff, day-to-day communication across departments is challenging, yet paramount to resource sharing and real-time problem-solving. To improve communication across departments, the laboratory at Seattle Children’s Hospital has been using daily huddles for several years, explains Dr. Joe Rutledge in this CAPcast.

In this CAPcast, Dr. Daniel Rhoads, Section Head of Microbiology at the Cleveland Clinic and Dr. Elitza Theel, Director of Infectious Disease Serology from Mayo Clinic explain the clinical use of antibody testing for SARS-CoV-2 and describe the work of the CAP’s Microbiology and Diagnostic Immunology and Flow Cytometry Committees to develop the new proficiency testing program SARS-CoV-2 Serology (COVS).

In this CAPcast, Dr. Vaught discusses why all biorepository directors need to understand the costs of setting up and operating their facilities and how to develop a business strategy.

In this CAPcast, Dr. Bobbi Pritt, Director of the Clinical Parasitology Laboratory and Co-Director of Vector-borne Diseases Laboratory Services at Mayo Clinic, discusses what pathologists and laboratories need to know about COV2.